MedTrace Logo

Reproductive Endocrinology Oxford Study (RepOx)

NCT05177562 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1175

Last updated 2022-01-04

No results posted yet for this study

Summary

This is a prospective observational study that aims to identify the underlying mechanisms of PolyCystic Ovarian Syndrome (PCOS) and associated comorbidities such as subfertility, miscarriage; and pregnancy complications such as gestational diabetes mellitus and Intrahepatic cholestasis of pregnancy (ICP). This will be achieved through cross-sectional observation and laboratory analyses.

Conditions

  • Polycystic Ovary Syndrome

Interventions

OTHER

No intervention

There is no intervention in this study

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Li Ka Shing Foundation

    collaborator OTHER

  • University of Oxford

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2028-09-01
Completion
2028-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05177562 on ClinicalTrials.gov